Transitioning from a biopharma organization that has spent years focused on research and development to an established, fully integrated drug company can be challenging, even when company executives have significant launch experience from other companies. In a short amount of time, biopharma companies have to make several decisions, such as whether to scale up the enterprise and customize the operational model for their first product launch.

To provide perspective on lessons learned from biopharma companies that have successfully transformed into commercial organizations, we’ve put together some of the key principles that biopharma executives should bear in mind as they scale up their organizations. Our proprietary approach to enterprise readiness is outlined in this Executive Insights to help management teams expertly deliver it at both corporate and functional levels, and ensure successful product launches — from the first, to several more down the road.

Sample Visuals

Related Insights